Skip to content

Clinical trials

Tuberculosis, Multidrug-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis, Multidrug-Resistant Clear all

129 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20071
20082
20096
20106
20114
20122
20137
20146
201512
20167
20177
20187
20198
202013
20218
202210
20236
20244
20253
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed77
Unknown status19
Recruiting15
Terminated7
Not yet recruiting6
Active, not recruiting3
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Global Alliance for TB Drug Development9
Huashan Hospital7
National Institute of Allergy and Infectious Diseases (NIAID)6
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Beijing Chest Hospital5
Foundation for Innovative New Diagnostics, Switzerland5
Medecins Sans Frontieres, Netherlands5
University Medical Center Groningen4
University of Cape Town4
Assistance Publique - Hôpitaux de Paris3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis, Multidrug-Resistant129
Tuberculosis56
Tuberculosis, Pulmonary29
Extensively Drug-Resistant Tuberculosis22
Mycobacterium Infections6
Bacterial Infections5
Latent Tuberculosis5
Disease3
HIV Infections3
Lung Diseases2

Trials

Showing 76 to 100 of 129. Each trial links to its page on Pharma Observatory.

29 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.